{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:04Z","timestamp":1792202404509,"version":"4.4.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.blre.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T18:35:54Z","timestamp":1450982154000},"page":"245-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies"],"prefix":"10.1016","volume":"30","author":[{"given":"Denis","family":"Noubouossie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel S.","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Ataga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2015.12.003_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.12.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2013-303773","article-title":"Sickle cell disease: a neglected chronic disease of increasing global health importance","volume":"100","author":"Chakravorty","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.blre.2015.12.003_bb0020","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"issue":"897","key":"10.1016\/j.blre.2015.12.003_bb0025","first-page":"e7","article-title":"Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease","volume":"119","author":"Stein","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2012.04697.x","article-title":"Pulmonary embolism in sickle cell disease: a case\u2013control study","volume":"10","author":"Novelli","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0040","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the cooperative study of sickle cell disease","volume":"12","author":"Naik","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0045","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","volume":"91\u20136","author":"Ataga","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2015.12.003_bb0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0031-1273087","article-title":"Thrombosis and sickle cell disease","volume":"37","author":"De Franceschi","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0055","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.024","article-title":"Sickle cell disease and venous thromboembolism","volume":"3","author":"Rahimi","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2015.12.003_bb0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOH.0b013e328363442f","article-title":"Hemostatic abnormalities in sickle cell disease","volume":"20","author":"Lim","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.hoc.2013.11.011","article-title":"Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics","volume":"28","author":"Pakbaz","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2015.12.003_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00282-996-0279-2","article-title":"Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease","volume":"38","author":"Nsiri","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.blre.2015.12.003_bb0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-2143(99)90149-X","article-title":"Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease","volume":"134","author":"Westerman","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001721-199504000-00001","article-title":"Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls","volume":"6","author":"Hagger","year":"1995","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"10.1016\/j.blre.2015.12.003_bb0085","first-page":"169","article-title":"Enhanced thrombin generation in children with sickle cell disease","volume":"71","author":"Peters","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1992.tb02989.x","article-title":"Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients","volume":"81","author":"Kurantsin-Mills","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0095","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","article-title":"Thrombophilia in sickle cell disease: the red cell connection","volume":"98","author":"Setty","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0100","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.1998.01121.x","article-title":"Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion","volume":"103","author":"Liesner","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078801","article-title":"Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy","volume":"8","author":"Colombatti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2015.12.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029786","article-title":"Association of coagulation activation with clinical complications in sickle cell disease","volume":"7","author":"Ataga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2015.12.003_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.blre.2015.12.003_bb0130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.blre.2015.12.003_bb0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/clinchem.2012.184077","article-title":"Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay","volume":"58","author":"Ninivaggi","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.blre.2015.12.003_bb0145","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/bjh.13641","article-title":"Coagulation activation in sickle cell trait: an exploratory study","volume":"171","author":"Amin","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0150","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.thromres.2012.08.307","article-title":"Characterization of the hypercoagulable state in patients with sickle cell disease","volume":"130","author":"Shah","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0155","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH11-10-0689","article-title":"The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles","volume":"107","author":"Gerotziafas","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.22206","article-title":"Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children","volume":"87","author":"Noubouossie","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2007.06785.x","article-title":"Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study","volume":"139","author":"Dargaud","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0170","doi-asserted-by":"crossref","first-page":"4060-4060","DOI":"10.1182\/blood.V124.21.4060.4060","article-title":"Hypercoagulability in sickle cell disease: the importance of the cellular component of blood","volume":"124","author":"Whelihan","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0175","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5858\/2005-129-760-TAHCIP","article-title":"Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease","volume":"129","author":"Yee","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2141.2012.09065.x","article-title":"Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis","volume":"157","author":"Setty","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0185","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2015.12.003_bb0190","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0195","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3324\/haematol.12632","article-title":"No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension","volume":"93","author":"van Beers","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0205","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1538-7836.2008.03177.x","article-title":"Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia","volume":"6","author":"Setty","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0210","doi-asserted-by":"crossref","first-page":"2215-2215","DOI":"10.1182\/blood.V122.21.2215.2215","article-title":"Heme potently stimulates tissue factor expression by peripheral blood monocytes: a novel mechanism for thrombosis in intravascular hemolytic diseases","volume":"122","author":"Rehani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2014.114728","article-title":"Excess of heme induces tissue factor-dependent activation of coagulation in mice","volume":"100","author":"Sparkenbaugh","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.21582","article-title":"Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse","volume":"85","author":"Solovey","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0225","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2003-10-3719","article-title":"Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia\/reoxygenation and inhibited by lovastatin","volume":"104","author":"Solovey","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/CH-131735","article-title":"Hypoxia\/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice","volume":"54","author":"Aufradet","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.blre.2015.12.003_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trsl.2009.10.004","article-title":"Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease","volume":"155","author":"Kollander","year":"2010","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0240","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood-2010-08-301366","article-title":"Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S","volume":"117","author":"Gavins","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0245","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3476(85)80669-7","article-title":"Reduction of contact factors in sickle cell disease","volume":"106","author":"Gordon","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.12.003_bb0255","first-page":"313","article-title":"Reduced plasma kininogen concentration during sickle cell crisis","volume":"41","author":"Verma","year":"1983","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.blre.2015.12.003_bb0260","first-page":"551","article-title":"Studies of the kallikrein-kinin system in patients with sickle cell anemia","volume":"75","author":"Miller","year":"1983","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.blre.2015.12.003_bb0265","first-page":"1","article-title":"How it all starts: initiation of the clotting cascade","volume":"28","author":"Smith","year":"2015","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.blre.2015.12.003_bb0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-015-0048-y","article-title":"Contact pathway of coagulation and inflammation","volume":"13","author":"Wu","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.blre.2015.12.003_bb0275","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1182\/blood-2012-03-306605","article-title":"Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation","volume":"119","author":"Morrissey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0280","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5858\/arpa.2012-0725-OA","article-title":"Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?","volume":"138","author":"Al-Humood","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.2007.06775.x","article-title":"Circulating DNA: a potential marker of sickle cell crisis","volume":"139","author":"Vasavda","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0290","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3324\/haematol.2013.088021","article-title":"Nucleosomes and neutrophil activation in sickle cell disease painful crisis","volume":"98","author":"Schimmel","year":"2013","journal-title":"Haematologica"},{"issue":"S2","key":"10.1016\/j.blre.2015.12.003_bb0295","first-page":"17","article-title":"Kininogen deficiency attenuates thrombin generation in a mouse model of sickle cell disease (ISTH Abstract)","volume":"13","author":"Sparkenbaugh","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0300","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2015.12.003_bb0305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2013.12.008","article-title":"A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation","volume":"133","author":"Jakubowski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0310","first-page":"323","article-title":"Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease","volume":"52","author":"Famodu","year":"1995","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.blre.2015.12.003_bb0315","first-page":"17","article-title":"Platelet activation during steady state sickle cell disease","volume":"14","author":"Westwick","year":"1983","journal-title":"J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb9880","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000204519","article-title":"Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis","volume":"89","author":"Papadimitriou","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0320","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R","article-title":"Disturbance of plasma and platelet thrombospondin levels in sickle cell disease","volume":"51","author":"Browne","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0325","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.1998.00627.x","article-title":"Platelet activation in patients with sickle cell disease","volume":"100","author":"Wun","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0330","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2010.08087.x","article-title":"Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity","volume":"149","author":"Proen\u00e7a-Ferreira","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0335","first-page":"17","article-title":"Platelet activation during steady state sickle cell disease","volume":"14","author":"Westwick","year":"1983","journal-title":"J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0345","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism","volume":"33","author":"Kenny","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2015.12.003_bb0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3476(80)80804-3","article-title":"Abnormalities of platelet aggregation in sickle cell disease","volume":"96","author":"Mehta","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.12.003_bb0355","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-3476(74)80504-4","article-title":"Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle-cell anemia","volume":"85","author":"Stuart","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.12.003_bb0360","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.12950","article-title":"The spleen and sickle cell disease: the sick(led) spleen","volume":"166","author":"Brousse","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0365","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0370","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood.V88.5.1873.1873","article-title":"Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations","volume":"88","author":"Wood","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0375","first-page":"2207","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"148","author":"Fadok","year":"1992","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.blre.2015.12.003_bb0380","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1073\/pnas.83.10.3311","article-title":"Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages","volume":"83","author":"McEvoy","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2015.12.003_bb0385","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1016\/S0021-9258(18)89189-X","article-title":"In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes","volume":"260","author":"Schroit","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2015.12.003_bb0390","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","article-title":"Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy","volume":"142","author":"Westerman","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0395","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/jth.12423","article-title":"The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells","volume":"11","author":"Whelihan","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0400","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood.V89.4.1121","article-title":"Pathophysiologic implications of membrane phospholipid asymmetry in blood cells","volume":"89","author":"Zwaal","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0405","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2012-05-427856","article-title":"Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation","volume":"120","author":"Whelihan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0410","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.V96.3.1119","article-title":"Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation","volume":"96","author":"Setty","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0415","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2141.2002.03445.x","article-title":"Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C","volume":"117","author":"Bezeaud","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0420","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MBC.0b013e32832ee915","article-title":"Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT","volume":"20","author":"Connor","year":"2009","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"10.1016\/j.blre.2015.12.003_bb0425","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.thromres.2014.09.019","article-title":"Measurement of procoagulant activity of microparticles in plasma: feasibility of new functional assays","volume":"134","author":"Marco","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0430","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","article-title":"Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease","volume":"94","author":"van Beers","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0435","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.thromres.2011.10.016","article-title":"Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays","volume":"130","author":"Noubouossie","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0440","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2009.09.102","article-title":"Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis","volume":"390","author":"van Tits","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2015.12.003_bb0445","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa: microparticle-driven thrombin generation","volume":"10","author":"Van Der Meijden","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2015.12.003_bb0450","first-page":"231","article-title":"Coagulation factor XII binding to apoptotic cells initiates thrombin generation (ISTH abstract)","volume":"13","author":"Yang","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0455","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11239-013-1028-3","article-title":"Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease","volume":"38","author":"Kasar","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.blre.2015.12.003_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087243","article-title":"Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia","volume":"9","author":"Nebor","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2015.12.003_bb0465","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1442-200X.2001.01476.x","article-title":"Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state","volume":"43","author":"Bayazit","year":"2001","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2015.12.003_bb0470","first-page":"710","article-title":"Factor VIII level correlates with hemolysis and may contribute to the hypercoagulability of children with sickle cell disease (ISTH abstract)","volume":"11","author":"Noubouossie","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0475","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.1975.tb00530.x","article-title":"Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica","volume":"30","author":"Leslie","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0480","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000205981","article-title":"Coagulation changes in sickle cell disease in early childhood","volume":"77","author":"Babiker","year":"1987","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0485","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1160\/TH08-10-0677","article-title":"Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease","volume":"101","author":"Zhou","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0490","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.2013.092635","article-title":"Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease","volume":"98","author":"Novelli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0495","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ajh.20653","article-title":"ADAMTS13 activity in sickle cell disease","volume":"81","author":"Schnog","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0500","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2010-08-302539","article-title":"The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0505","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2007.12.004","article-title":"Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia","volume":"122","author":"Krishnan","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0510","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000204390","article-title":"Blood proteins C and S in sickle cell disease","volume":"90","author":"el-Hazmi","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0515","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.1997.2663083.x","article-title":"Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels?","volume":"98","author":"Wright","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0520","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1021\/bi9626160","article-title":"Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site","volume":"36","author":"McDonald","year":"1997","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.blre.2015.12.003_bb0525","doi-asserted-by":"crossref","first-page":"20288","DOI":"10.1016\/S0021-9258(19)47060-9","article-title":"Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides","volume":"264","author":"Schwalbe","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2015.12.003_bb0530","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.2830470409","article-title":"Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S","volume":"47","author":"Lane","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0535","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.169.5.2580","article-title":"Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells","volume":"169","author":"Webb","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2015.12.003_bb0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15513810109168816","article-title":"Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology","volume":"20","author":"Stuart","year":"2001","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0545","first-page":"37","article-title":"Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome","volume":"44","author":"Onyemelukwe","year":"1992","journal-title":"Trop Geogr Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0550","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1993.tb04671.x","article-title":"Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II","volume":"83","author":"Porter","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0555","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.STR.9.1.45","article-title":"Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation","volume":"9","author":"Merkel","year":"1978","journal-title":"Stroke J Cereb Circ"},{"key":"10.1016\/j.blre.2015.12.003_bb0560","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.410200606","article-title":"Sickle cell anemia and central nervous system infarction: a neuropathological study","volume":"20","author":"Rothman","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.blre.2015.12.003_bb0565","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0570","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/hupa.2002.128059","article-title":"Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases","volume":"33","author":"Haque","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2015.12.003_bb0575","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0580","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00247-014-2880-9","article-title":"Extracranial carotid arteriopathy in stroke-free children with sickle cell anemia: detection by submandibular Doppler sonography","volume":"44","author":"Verlhac","year":"2014","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.blre.2015.12.003_bb0585","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3324\/haematol.2010.022624","article-title":"Extracranial internal carotid arterial disease in children with sickle cell anemia","volume":"95","author":"Deane","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0590","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1182\/blood-2011-03-337915","article-title":"Cervical carotid artery disease in sickle cell anemia: clinical and radiological features","volume":"118","author":"Telfer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0595","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/675997","article-title":"Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease","volume":"4","author":"Linguraru","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1016\/j.blre.2015.12.003_bb0600","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0605","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjh.12300","article-title":"Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia","volume":"161","author":"Connes","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0610","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0615","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2007-06-097188","article-title":"Genetic endothelial systems biology of sickle stroke risk","volume":"111","author":"Milbauer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0620","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archinte.1974.00320160118010","article-title":"Hemolysis in sickle cell disease","volume":"133","author":"Bensinger","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3324\/haematol.12318","article-title":"Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!","volume":"93","author":"Gladwin","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0630","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0635","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1160\/TH14-02-0167","article-title":"Protease-activated receptor signalling by coagulation proteases in endothelial cells","volume":"112","author":"Rezaie","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0640","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/jth.12198","article-title":"Fibrocytes mediate intimal hyperplasia post-vascular injury and are regulated by two tissue factor-dependent mechanisms","volume":"11","author":"Chen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0645","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0650","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2015.12.003_bb0655","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/GRF.0b013e31825cfe7b","article-title":"Prevention and treatment of venous thromboembolism in pregnancy","volume":"55","author":"James","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.blre.2015.12.003_bb0660","first-page":"e1","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199:125","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2015.12.003_bb0665","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0670","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10995-012-1216-3","article-title":"Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population","volume":"17","author":"Boulet","year":"2013","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.blre.2015.12.003_bb0675","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.thromres.2014.09.037","article-title":"Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis","volume":"134","author":"Seaman","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0680","first-page":"685","article-title":"Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes","volume":"28","author":"Costa","year":"2015","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"issue":"S1","key":"10.1016\/j.blre.2015.12.003_bb0685","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0049-3848(15)50442-8","article-title":"Sickle cell disease and venous thromboembolism in pregnancy and the puerperium","volume":"135","author":"Noubouossie","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0690","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0695","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0140-6736(00)04821-2","article-title":"Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease","volume":"357","author":"Kirkham","year":"2001","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.blre.2015.12.003_bb0700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.2830450402","article-title":"Alpha thalassemia and stroke risk in sickle cell anemia","volume":"45","author":"Adams","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0705","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2001-12-0306","article-title":"Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease","volume":"100","author":"Vi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0710","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng1533","article-title":"Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia","volume":"37","author":"Sebastiani","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2015.12.003_bb0715","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/09537104.2012.749397","article-title":"Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications","volume":"24","author":"Tantawy","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2015.12.003_bb0720","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1055\/s-0037-1615083","article-title":"Reduced protein C levels\u2014a contributory factor for stroke in sickle cell disease","volume":"79","author":"Khanduri","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0725","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/088307389701200103","article-title":"Protein C and protein S activity in sickle cell disease and stroke","volume":"12","author":"Tam","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.blre.2015.12.003_bb0730","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ejh.12113","article-title":"Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment","volume":"91","author":"Noubouossie","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0735","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","article-title":"Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0740","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/asheducation-2014.1.438","article-title":"Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease","volume":"2014","author":"Quinn","year":"2014","journal-title":"Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2015.12.003_bb0745","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1212\/WNL.56.8.1109","article-title":"Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease","volume":"56","author":"Schatz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2015.12.003_bb0750","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0755","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0760","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0765","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201105-0783OC","article-title":"Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease","volume":"184","author":"Mekontso Dessap","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0770","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0775","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2006.06110.x","article-title":"Pulmonary hypertension in patients with sickle cell disease: a longitudinal study","volume":"134","author":"Ataga","year":"2006","journal-title":"Br J Haematol"},{"issue":"25 Suppl","key":"10.1016\/j.blre.2015.12.003_bb0780","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2015.12.003_bb0785","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0790","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s11999-008-0148-0","article-title":"Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head","volume":"466","author":"Glueck","year":"2008","journal-title":"Clin Orthop"},{"key":"10.1016\/j.blre.2015.12.003_bb0795","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.thromres.2008.04.001","article-title":"Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head","volume":"123","author":"Kang","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0800","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bjh.13110","article-title":"Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease","volume":"168","author":"Marsh","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0805","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0810","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.blre.2015.12.003_bb0815","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood-2006-11-057893","article-title":"Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia","volume":"110","author":"Zimmerman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0820","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/pbc.20819","article-title":"Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease","volume":"47","author":"Kratovil","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.12.003_bb0825","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/pbc.25529","article-title":"Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort","volume":"62","author":"Lagunju","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.12.003_bb0830","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.12323","article-title":"The effect of hydroxcarbamide therapy on survival of children with sickle cell disease","volume":"161","author":"de C","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0835","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajh.21986","article-title":"Long-term results using hydroxyurea\/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload","volume":"86","author":"Greenway","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0840","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.10205","article-title":"Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)","volume":"71","author":"Sumoza","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0845","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ajh.22142","article-title":"Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke","volume":"86","author":"Ali","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0850","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/pbc.25563","article-title":"Hydroxyurea use in prevention of stroke recurrence in children with sickle cell disease in a developing country: a cost effectiveness analysis","volume":"62","author":"Cunningham-Myrie","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.12.003_bb0855","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0860","unstructured":"NIH ends Transcranial Doppler (TCD) with Transfusions Changing to Hydroxyurea (TWiTCH) clinical trial due to early results. Available from: http:\/\/www.nih.gov\/news\/health\/nov2014\/nhlbi-19.htm"},{"key":"10.1016\/j.blre.2015.12.003_bb0865","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3324\/haematol.2012.073619","article-title":"Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children","volume":"98","author":"N\u00e9bor","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.12.003_bb0870","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000362148","article-title":"Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia","volume":"133","author":"Brunetta","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0875","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/08880010390220090","article-title":"The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study","volume":"20","author":"Koc","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2015.12.003_bb0880","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0885","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0890","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the stroke prevention trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.12.003_bb0895","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2011.08897.x","article-title":"Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles","volume":"156","author":"Mahfoudhi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0900","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1995.tb05607.x","article-title":"Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?","volume":"90","author":"Wolters","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0905","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1175","article-title":"Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study","volume":"68","author":"Schnog","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0910","first-page":"574","article-title":"Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises","volume":"66","author":"Chaplin","year":"1989","journal-title":"East Afr Med J"},{"key":"10.1016\/j.blre.2015.12.003_bb0915","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0920","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2002-02-0626","article-title":"Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin","volume":"100","author":"Matsui","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0925","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10753-012-9503-0","article-title":"Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses","volume":"35","author":"Zhao","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.blre.2015.12.003_bb0930","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0935","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2015-01-625707","article-title":"Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice","volume":"126","author":"Arumugam","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0940","first-page":"199","article-title":"Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises","volume":"15","author":"Cabannes","year":"1984","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.blre.2015.12.003_bb0945","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2007.06787.x","article-title":"Phase I study of eptifibatide in patients with sickle cell anaemia","volume":"139","author":"Lee","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0950","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2013.08.002","article-title":"A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease","volume":"132","author":"Desai","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2015.12.003_bb0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-6-17","article-title":"A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease","volume":"6","author":"Wun","year":"2013","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.blre.2015.12.003_bb0960","article-title":"A multinational trial of prasugrel for sickle cell vaso-occlusive events","author":"Heeney","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0965","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood.V114.22.2587.2587","article-title":"Thrombin generation in sickle cell disease: insights from computerized automated thrombography. (ASH Abstract)","volume":"114","author":"Betal","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.12.003_bb0970","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM196307252690403","article-title":"Long-term anticoagulation in sickle-cell disease","volume":"269","author":"Salvaggio","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.12.003_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000291","article-title":"Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study","volume":"37","author":"Styles","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2015.12.003_bb0980","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb0985","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0038-1661088","article-title":"A double-blind trial of ticlopidine in sickle cell disease","volume":"51","author":"Semple","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2015.12.003_bb0990","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.12.003_bb0995","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000207105","article-title":"Therapeutic effect of aspirin in sickle cell anaemia","volume":"66","author":"Osamo","year":"1981","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2015.12.003_bb1000","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1650055","article-title":"Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises","volume":"43","author":"Chaplin","year":"1980","journal-title":"Thromb Haemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1500096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1500096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:01:38Z","timestamp":1718276498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X1500096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":201,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0268960X1500096X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.12.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}